Grob JJ, Dreno B, de la Salmonière P, Delaunay M, Cupissol D, Guillot B, et al. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. Lancet 1998 Jun 27;351(9120):1905-10 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/9654256.
Compare quality appraisals for each clinical question
- What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?